References
- Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151–7.
- Cestari R, Braga M, Missale G, Ravelli P, Burroughs AK. Haemodynamic effect of triglycyl-lysine-vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial. J Hepatol 1990;10:205–10.
- Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865–8.
- Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, et al. Systemic and portal haemodynamic changes following trigly- cyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis. J Hepatol 1990; 10: 370–4.
- Möller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000;20:51–9.
- Kiszka-Kanowitz M, Henriksen JH, Möller S, Bendtsen F. Blood volume distribution in patients with cirrhosis. Aspects of the gamma-camera technique. J Hepatol 2001;35:605–12.
- Srivastava SC, Chervu LR. Radionuclide-labeled red blood cells: current status and future prospects. Semin Nucl Med 1984;14:68–82.
- Henriksen JH, Bendtsen F, Sorensen TI, Stadeager C, Ring- Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989;97:1506–13.
- Johansen LB, Videbaek R, Hammerum M, Norsk P. Underestimation of plasma volume changes in humans by hematocrit/ hemoglobin method. Am J Physiol 1998;274:R126–30.
- Möller S, Henriksen JH, Bendtsen F. Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender. Am J Physiol Gastrointest Liver Physiol 2003; 284: G970–9.
- Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage (Cochrane Review). Cochrane Database. Syst Rev 2001;1:CD002147.
- Hadengue A, Gadano A, Moreau R, Giostra E, Durand F, Valla D, et al. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 1998;29:565–70.
- Mulkay JP, Louis H, Donckier V, Bourgeois N, Adler M, Deviere J, et al. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. Acta Gastroenterol Belg 2001;64:15–9.
- Uriz J, Gines P, Cardenas A, Sort P, Jimenez W, Salmeron JM, et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 2000;33:43–8.
- Lebrec D. A discussion of how terlipressin limits mortality in cases of bleeding oesophageal varices. Eur J Gastroenterol Hepatol 1998;10:549–52.
- Freeman JG, Barton JR, Record CO. Haemodynamic responses to 1.25 and 2 mg of terlipressin intravenously in man. Aliment Pharmacol Ther 1988;2: 361–7.
- Hopf HB, Stuhmeier KD, Klement W, Langen KJ, Peters J. Effects of arginine-vasopressin on regional blood volume distribution in supine humans. Basic Res Cardiol 1993;88:297–306.
- Koskenvao JW, Saraste M, Niemi P, Knuuti J, Sakuma H, Toikka JO, et al. Correlation of transthoracic Doppler echocardiography and magnetic resonance imaging in measuring left anterior descending artery flow velocity and time-course of dipyridamole-induced coronary flow increase. Scand J Clin Lab Invest 2003;63:65–72.
- Newman DG, Callister R. The non-invasive assessment of stroke volume and cardiac output by impedance cardiography: a review. Aviat Space Environ Med 1999;70:780–9.
- Raaijmakers E, Faes TJ, Scholten RJ, Goovaerts HG, Heethaar RM. A meta-analysis of published studies concerning the validity of thoracic impedance cardiography. Ann NY Acad Sci 1999; 873:121–7.